help button home button Am J Pathol ASIP WHAT IS IT?
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Originally published online as doi:10.2353/ajpath.2008.070576 on May 8, 2008

Published online before print May 8, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ajpath.2008.070576v1
172/6/1482    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Chimenti, C.
Right arrow Articles by van der Velden, J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chimenti, C.
Right arrow Articles by van der Velden, J.
(American Journal of Pathology. 2008;172:1482-1490.)
© 2008 American Society for Investigative Pathology
DOI: 10.2353/ajpath.2008.070576

Myofilament Degradation and Dysfunction of Human Cardiomyocytes in Fabry Disease

Cristina Chimenti*{dagger}, Nazha Hamdani{ddagger}, Nicky M. Boontje{ddagger}, Francesco DeCobelli§, Antonio Esposito§, Jean G.F. Bronzwaer{ddagger}, Ger J.M. Stienen{ddagger}, Matteo A. Russo{dagger}, Walter J. Paulus{ddagger}, Andrea Frustaci*|| and Jolanda van der Velden{ddagger}

From the Heart and Great Vessels "Attilio Reale" Department* and Experimental Medicine and Pathology Department, La Sapienza University, Rome, Italy; Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele La Pisana,{dagger} Rome, Italy; Radiology Department,§ San Raffaele Hospital, Milan, Italy; the Molecular and Cellular Cardiology Laboratory,|| National Institute for Infectious Diseases, "Lazzaro Spallanzani," Rome, Italy; and the Laboratory of Physiology,{ddagger} Institute for Cardiovascular Research, Vrije Universiteit University Medical Center, Amsterdam, The Netherlands

Early detection of myocardial dysfunction in Fabry disease (FD) cardiomyopathy suggests the contribution of myofilament structural alterations. Six males with untreated FD cardiomyopathy submitted to cardiac studies, including tissue Doppler imaging and left ventricular endomyocardial biopsy. Active and resting tensions before and after treatment with protein kinase A (PKA) were determined in isolated Triton-permeabilized cardiomyocytes. Cardiomyocyte cross-sectional area, glycosphingolipid vacuole area, myofibrillolysis, and extent of fibrosis were also determined. Biopsies of mitral stenosis in patients with normal left ventricles served as controls. Active tension was four times lower in FD cardiomyocytes and correlated with extent of myofibrillolysis. Resting tension was six times higher in FD cardiomyocytes than in controls. PKA treatment decreased resting tension but did not affect active force. Protein analysis revealed troponin I and desmin degradation products. FD cardiomyocytes were significantly larger and filled with glycosphingolipids. Fibrosis was mildly increased compared with controls. Tissue Doppler imaging lengthening and shortening velocities were reduced in FD cardiomyocytes compared with controls, correlating with resting and active tensions, respectively, but not with cardiomyocyte area, percentage of glycosphingolipids, or extent of fibrosis. In conclusion, myofilament degradation and dysfunction contribute to FD cardiomyopathy. Partial reversal of high resting tension after pharmacological PKA treatment of cardiomyocytes suggests potential benefits from enzyme replacement therapy and/or energy-releasing agents.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Society for Investigative Pathology.